Literature DB >> 34417923

Small Intestinal Bacterial Overgrowth In Various Functional Gastrointestinal Disorders: A Case-Control Study.

Kee Huat Chuah1, Mung Seong Wong2,3, Phei Oon Tan2,3, Sze Zee Lim4, Keng Hau Beh4, Sufian Chern Siong Chong2,3, Khairil Khuzaini Zulkifli2,5, Abdul Malik Thalha6, Sanjiv Mahadeva6, Yeong Yeh Lee2,3.   

Abstract

INTRODUCTION: Small intestinal bacterial overgrowth (SIBO) is prevalent in irritable bowel syndrome (IBS), but its' association with other functional gastrointestinal disorders (FGIDs) is less certain. This study aimed to explore SIBO in a multi-racial Asian population with various FGIDs compared to non-FGID controls.
METHODOLOGY: Consecutive Asian adults with Rome III diagnosed common FGIDs (functional dyspepsia/FD, IBS and functional constipation/FC) and non-FGID controls were subjected to glucose breath testing, with hydrogen (H2) and methane (CH4) levels determined.
RESULTS: A total of 244 participants (FGIDs n = 186, controls n = 58, median age 45 years, males 36%, Malay ethnicity 76%) were recruited. FGIDs had a higher prevalence trend of SIBO compared to controls (16% FGIDs vs. 10% controls, p = 0.278) with 14% in FD, 18% in IBS and 17% in FC. Compared to controls, SIBO was associated with diarrhoea-predominant IBS (IBS-D) (24% vs. 10%, P = 0.050) but not with other types of FGIDs. IBS-D remained an independent predictor of SIBO (OR = 2.864, 95% CI 1.160-7.071, p = 0.023) but not PPI usage nor history of diabetes (both p > 0.050) at multivariate analysis. Compared to controls, SIBO in IBS-D was associated with an elevated H2 level (≥ 20 ppm from baseline) (18% vs. 3%, p = 0.017), but not CH4 levels (≥ 10 ppm) (9% vs. 7%, p = 0.493). In addition, no difference was found in the prevalence of methane-positive SIBO between chronic constipation (constipation-predominant IBS and FC) compared to controls (9% vs. 7%, P = 0.466).
CONCLUSION: SIBO is prevalent amongst multi-ethnic Asian adults with and without FGIDs. Amongst various FGIDs, only IBS-D is significantly associated with SIBO.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Breath test; Diarrhoea; Functional constipation; Functional dyspepsia; Irritable bowel syndrome; SIBO

Mesh:

Substances:

Year:  2021        PMID: 34417923     DOI: 10.1007/s10620-021-07227-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  1 in total

1.  Small bowel bacterial overgrowth in patients with irritable bowel syndrome: the first study in iran.

Authors:  Mehdi HayatBakhsh Abbasi; MohammadJavad Zahedi; Sodaif Darvish Moghadam; Sara Shafieipour; Mahroo HayatBakhsh Abbasi
Journal:  Middle East J Dig Dis       Date:  2015-01
  1 in total
  2 in total

Review 1.  Bi-Directionality of the Microbiota-Gut-Brain Axis in Patients With Functional Dyspepsia: Relevance of Psychotherapy and Probiotics.

Authors:  Sophia Kristina Rupp; Andreas Stengel
Journal:  Front Neurosci       Date:  2022-02-28       Impact factor: 4.677

2.  Antimicrobial treatment improves tryptophan metabolism and mood of patients with small intestinal bacterial overgrowth.

Authors:  Cezary Chojnacki; Tomasz Popławski; Paulina Konrad; Michał Fila; Janusz Błasiak; Jan Chojnacki
Journal:  Nutr Metab (Lond)       Date:  2022-09-27       Impact factor: 4.654

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.